GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
88 hedge funds and large institutions have $342M invested in GenMark Diagnostics, Inc in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
0% more funds holding
Funds holding: 88 → 88 (0)
1% less capital invested
Capital invested by funds: $345M → $342M (-$2.64M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $231K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$10.2M |
| 2 |
CCM
Cadian Capital Management
New York
|
+$8.49M |
| 3 |
JP Morgan Chase
New York
|
+$2.55M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.5M |
| 5 |
Jennison Associates
New York
|
+$1.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$8.22M |
| 2 |
FAM
Fred Alger Management
New York
|
-$6.88M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$3.76M |
| 4 |
VAM
Visium Asset Management
New York
|
-$3.05M |
| 5 |
Parnassus Investments
San Francisco,
California
|
-$1.5M |
GNMK Hedge Fund Activity: Q4 2015 in Review
88 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2015, worth a combined $342M — down 0.76% from $345M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GNMK positions and 8 closed out — a net gain of 2 holders — while 30 added to existing stakes and 26 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $10.2M. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $8.22M sold.
- 88 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $342M of GenMark Diagnostics, Inc stock for Q4 2015, down 0.76% quarter-over-quarter.
- 10 funds opened new GenMark Diagnostics, Inc positions in Q4 2015 and 8 closed out, a net change of +2 holders.
- The largest GenMark Diagnostics, Inc buyer in Q4 2015 was Morgan Stanley, an estimated $10.2M added.
- The largest GenMark Diagnostics, Inc seller in Q4 2015 was Massachusetts Financial Services, an estimated $8.22M sold.
Based on aggregated 13F filings for Q4 2015.